Baidu
map

Diabetes Care:减肥术降血糖和改善β细胞功能

2012-09-05 高晓方 医学论坛网

  欧洲学者的一项研究表明,Roux-en-Y胃旁路手术(RYGB)可降低血糖浓度和改善β细胞功能,并且术后胃肠道葡萄糖吸收低于对照者。论文于2012年8月24日在线发表于《糖尿病护理》(Diabetes Care)杂志。   此项研究共纳入6例非糖尿病性病态肥胖患者。通过与肥胖对照者和消瘦对照者对比,在RYGB手术之前(pre-OP)和(7±1)个月后(post-OP)评估手术对β细

  欧洲学者的一项研究表明,Roux-en-Y胃旁路手术(RYGB)可降低血糖浓度和改善β细胞功能,并且术后胃肠道葡萄糖吸收低于对照者。论文于2012年8月24日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  此项研究共纳入6例非糖尿病性病态肥胖患者。通过与肥胖对照者和消瘦对照者对比,在RYGB手术之前(pre-OP)和(7±1)个月后(post-OP)评估手术对β细胞功能以及骨骼肌、肝脏和肠道内葡萄糖转换率的影响。

  患者术后体重减轻(35±3)kg。RYGB后整体胰岛素敏感性(M/I)增加,但仍显著低于消瘦对照者。M/I与脂肪量密切相关。在OGTT测定期间,post-OP使120至180分钟血糖降低≥15%,胰高血糖素样肽-1(GLP-1)动态曲线下面积升高29倍,并且与β细胞分泌增加84%密切相关。术后胰岛素源性指数升高。术后胰岛素刺激胰岛素分泌较术前升高52%。手术前后胃肠道葡萄糖吸收无明显变化。

 

  链接:Anderwald CH, Tura A, Promintzer-Schifferl M, Prager G, Stadler M, Ludvik B, Esterbauer H, Bischof MG, Luger A, Pacini G, Krebs M.Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery.Diabetes Care. 2012 Aug 24

  拓展阅读:

           NEJM:减肥手术后15年内2型糖尿病发生率降低百分之七十八

           减肥术提高糖尿病肾病缓解率

           糖尿病病程较短者减肥术后糖尿病不易复发

           Lancet:减肥手术治疗2型糖尿病

           肥胖糖尿病患者减肥手术表现优于药物治疗

           改善2型糖尿病肥胖患者胰岛素抵抗,减肥手术优于艾塞那肽 

    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1636565, encodeId=0fa81636565dd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Oct 15 20:07:00 CST 2012, time=2012-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759193, encodeId=7bad1e59193ec, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Jan 14 17:07:00 CST 2013, time=2013-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972220, encodeId=2fc319e222071, content=<a href='/topic/show?id=d8e319241a4' target=_blank style='color:#2F92EE;'>#β细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19241, encryptionId=d8e319241a4, topicName=β细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70fe497, createdName=paperyu, createdTime=Tue Dec 04 16:07:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901002, encodeId=095c1901002f9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 02 00:07:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648725, encodeId=16ba1648e25ce, content=<a href='/topic/show?id=79ad9820ef7' target=_blank style='color:#2F92EE;'>#降血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98207, encryptionId=79ad9820ef7, topicName=降血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a53c23663172, createdName=yangeasy, createdTime=Sun Nov 04 05:07:00 CST 2012, time=2012-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675613, encodeId=97a516e561351, content=<a href='/topic/show?id=a678312e289' target=_blank style='color:#2F92EE;'>#减肥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31272, encryptionId=a678312e289, topicName=减肥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ee227270207, createdName=kksonne, createdTime=Sat Jan 19 13:07:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586765, encodeId=d3dd1586e656a, content=<a href='/topic/show?id=a6d1e7821de' target=_blank style='color:#2F92EE;'>#细胞功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77821, encryptionId=a6d1e7821de, topicName=细胞功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618819, encodeId=7d651618819cc, content=<a href='/topic/show?id=007419239ca' target=_blank style='color:#2F92EE;'>#β细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19239, encryptionId=007419239ca, topicName=β细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b69919964433, createdName=ms24272190615788285182, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]

相关资讯

改善2型糖尿病肥胖患者胰岛素抵抗,减肥手术优于艾塞那肽

  中国医科大学附属盛京医院普外科一项研究显示,对于2型糖尿病肥胖患者,胃旁路手术在控制体重和改善胰岛素抵抗等方面均优于艾塞那肽治疗。研究于3月23日在线发表于《肥胖外科学》(Obes Surg)。   研究纳入该院2009年1月~2010年1月接受减肥手术或艾塞那肽治疗的2型糖尿病肥胖患者,收集的数据包括体重改变、血糖、胰岛素变化、HbA1C以及患者的主观评分。结果显示,相比艾塞那肽

减肥术改善肥胖者肾脏功能

  2012年6月17~22日,美国代谢和肥胖病外科学会(ASMBS)第29届年会在加利福尼亚州圣地亚哥隆重召开。来自敏盛总医院和国立台湾大学医院的一项研究表明,伴有慢性肾脏病(CKD)的严重肥胖患者在减肥手术后1年内,肾功能得到明显的改善。研究发现,在1年内,患者的病情由中度变为轻度,或由轻度变为正常。   “利用减肥手术我们消除了慢性肾脏病的两大主要诱因——高血糖和高血压,”来自台湾敏盛总医

减肥术提高糖尿病肾病缓解率

  2012年6月17~22日,美国代谢和肥胖病外科学会第29届年会在加利福尼亚州圣地亚哥隆重召开。来自俄亥俄州克利夫兰医院肥胖病与代谢研究所的一项最新研究表明,对于众多肥胖型糖尿病患者,一种最令人恐惧的2型糖尿病的并发症是可以通过减肥手术得到缓解或彻底预防。   研究发现,术后5年,近60%的伴有糖尿病肾病的肥胖病人得到恢复,而糖尿病肾病是终末期肾病的首要原因。另外,在手术时没有肾病的糖尿病肥

机器人辅助降低减肥术并发症

  2012年6月22日,在加利福尼亚州圣地亚哥召开的美国代谢和肥胖病外科学会(ASMBS)第29届年会上报告的一项新研究表明,机器人辅助的腹腔镜下胃旁路手术可能减少早期并发症和死亡。   来自德克萨斯、缅因和佛罗里达大型减肥中心的研究者报告称,在连续1,695例机器人辅助腹腔镜下胃旁路手术后,30天内没有出现死亡,主要并发症发生率为0.3%。手术在2003至2011年间进行,手术患者平均体重指

减肥选择胃袖状切除术或更安全

  2012年6月20日,在第29届美国代谢与肥胖病外科学会年会上,来自斯坦福大学、佛罗里达州克利夫兰诊所和圣地亚哥海军医学中心的研究均表明,腹腔镜下胃袖状切除术(LSG)越来越普及,其安全性较腹腔镜下胃旁路术或胃囊带术相同或更安全。   研究1:斯坦福大学研究者分析了2007~2010年间近27万例代谢和肥胖病外科手术的安全性资料。近1.6万例是胃袖状切除术,其30天的严重并发症发生率小于1%

Baidu
map
Baidu
map
Baidu
map